REFERENCES
- SpeddingM.Reasons why stroke trials underestimate the neuroprotective effects of drugs.Stroke.200233 32432511779937
- The PROGRESS Collaborative Group. Effects of blood pressure lowering with perindopril and indapainide therapy on dementia and cognitive decline in patients with cerebrovascular disease.Arch Intern Med.20031631069107512742805
- DufouilC.ChalmersJ.CoskunO.et al.Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke.Circulation.20051121644165016145004
- CollisMG.Integrative pharmacology and drug discovery - is the tide turning?Nature Drug Discovery.2006 5377379
- FoordSM.BonnerTl.NeubigRR.et al.International Union of Pharmacology. XLVI. G protein-coupled receptor list.Pharmacol Rev.2005227928815914470
- MarkhamA.CameronI.FranklinP.SpeddingM.BDNF increases mitochondrial respiratory coupling, and glutamate metabolism, at complex I, but not complex II.EurJNeurosci.20042011891196
- KenakinT.New concepts in drug discovery: collateral efficacy and permissive antagonism.Nature Drug Discovery.20054919927
- LooH.HaleA.D'haenenH.Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT2c antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study.Int Clin Psychopharmacol.20021723924712177586
- KennedySH.EmsleyR.Placebo-controlled trial of agomelatine in the treatment of major depressive disorder.Eur Neuropsychopharmacol.2006169310016249073
- SpeddingM.JayT.Costa e SilvaJ.PerretL.A pathophysiological paradigm for the therapy of psychiatric disease.Nature Drug Discovery.20054467476
- RocherC.SpeddingM.MunozC.JayT.Acute stress-induced changes in cortical synaptic plasticity: interactions with antidepressants.Cereb Coitex.200414224229
- cEwenBS.OliéJP.Neurobiology of mood, anxiety and emotions, as revealed by studies of a unique antidepressant: tianeptine.Mol Psych.200510525537
- aybergHS.LozanoA.VoonV.et al.Deep brain stimulation for treatment resistant depression.Neuron.20054565166015748841